KUALA LUMPUR, 7 Oktober — Kerajaan melalui Kementerian Kesihatan (KKM) hari ini menandatangani surat akujanji (Letter of Undertaking) pembelian ubat antiviral Molnupiravir bagi menambah pilihan rawatan inovatif baharu dalam melawan COVID-19.
By Bernama • January 26, 2024 • 10:33 am
By Bernama • January 26, 2024 • 9:55 am
By Bernama • January 26, 2024 • 8:09 am
By Bernama • January 26, 2024 • 8:18 am
By TVS • January 26, 2024 • 8:24 am